Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma.

被引：1
|
作者：
Siegel, Abby B.
El-Khoueiry, Anthony B.
Finn, Richard S.
Guthrie, Katherine
Venook, Alan P.
Blanke, Charles David
Brown, Robert S.
机构：
[1] Columbia Univ, New York, NY USA
[2] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
[6] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.401
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
401
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I Trial of Sorafenib Following Liver Transplantation in Patients with High-Risk Hepatocellular Carcinoma
    Siegel, Abby B.
    El-Khoueiry, Anthony B.
    Finn, Richard S.
    Guthrie, Katherine A.
    Goyal, Abhishek
    Venook, Alan P.
    Blanke, Charles D.
    Verna, Elizabeth C.
    Dove, Lorna
    Emond, Jean
    Kato, Tomoaki
    Samstein, Benjamin
    Busuttil, Ronald
    Remotti, Helen
    Coffey, Amy
    Brown, Robert S., Jr.
    LIVER CANCER, 2015, 4 (02) : 115 - 125
  • [2] Phase I trial of sorafenib in high-risk hepatocellular carcinoma (HCC) patients after liver transplantation
    Siegel, Abby B.
    El-Khoueiry, Anthony B.
    Finn, Richard S.
    Blanke, Charles Davic
    Hidalgo, Rosa
    Brown, Robert S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [3] Phase I trial of sorafenib in high-risk hepatocellular carcinoma (HCC) patients after liver transplantation (LT)
    Siegel, A. B.
    Hsu, S. X.
    Becker, K. D.
    Anderson, S.
    Clark-Garvey, S.
    Hidalgo, R.
    Tsushima, D.
    Matushansky, I.
    Emond, J.
    Brown, R. S., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Multicenter phase I trial of sorafenib (S) in high-risk hepatocellular carcinoma (HCC) patients after liver transplantation (LT)
    Siegel, Abby B.
    El-Khoueiry, Anthony B.
    Finn, Richard S.
    Goyal, Abhishek
    Blanke, Charles David
    Brown, Robert S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [5] Phase I trial of sorafenib in hepatocellular carcinoma (HCC) patients after liver transplantation (LT).
    Siegel, A. B.
    Hidalgo, R.
    Tsushima, D.
    Zaretsky, J.
    Emond, J.
    Kato, T.
    Brown, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Phase I Adjuvant Trial of Sorafenib in Patients with Hepatocellular Carcinoma after Orthotopic Liver Transplantation
    Jia, Ning
    Liou, Iris
    Halldorson, Jeffrey
    Carithers, Robert
    Perkins, James
    Reyes, Jorge
    Yeh, Matthew
    Stohr, Elizabeth
    Rao, Sujata
    Lin, Edward H.
    ANTICANCER RESEARCH, 2013, 33 (06) : 2797 - 2800
  • [7] Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
    Po-Chih Yang
    Cheng-Maw Ho
    Rey-Heng Hu
    Ming-Chih Ho
    Yao-Ming Wu
    Po-Huang Lee
    World Journal of Hepatology, 2016, 8 (31) : 1309 - 1317
  • [8] Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
    Yang, Po-Chih
    Ho, Cheng-Maw
    Hu, Rey-Heng
    Ho, Ming-Chih
    Wu, Yao-Ming
    Lee, Po-Huang
    WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (31) : 1309 - 1317
  • [9] Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
    Shetty, Kirti
    Dash, Chiranjeev
    Laurin, Jacqueline
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [10] Expanded Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma.
    Kim, Jong Man
    Lee, Sanghoon
    Kim, Tae-Seok
    Moon, Hyunghwan
    Roh, Youngnam
    Song, Sanghyun
    Shin, Milljae
    Kwon, Choon Hyuck David
    Kim, Sung Joo
    Joh, Jae-Won
    Lee, Suk-Koo
    LIVER TRANSPLANTATION, 2012, 18 : S207 - S207
12345